InsiderTrades

Form 4 for DBD DIEBOLD NIXDORF, Inc

Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-01 · accession 0001719391-26-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-03-09 2026-03-01 DBD Sesplankis Jeffrey M SVP, CAO F - Tax $80.00 -672 5,129 -12% -$53.8K
2026-03-09 2026-03-01 DBD Sesplankis Jeffrey M SVP, CAO A - Grant $0.00 +2,215 7,344 +43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-01 F D 672 $80.00 5,129 D — — (F1) Shares withheld pursuant to exercise of tax withholding right under the 2023 Equity and Incentive Plan, as amended. (F2) Number includes Restricted Stock Units.
2 Common Common Stock 2026-03-01 A A 2,215 $0.00 7,344 D — — (F3) Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock. (F2) Number includes Restricted Stock Units.